RxDoctor Payments Data

Mamie Chan

Optometrist · Albuquerque, NMNPI 1164536165

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (35.2%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Johnson & Johnson Vision Care, Inc. accounts for 79.8% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2024 at $3,980 and has fallen 99.3% since, to $28 in 2025. Among optometrist clinicians in NM with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,811in general payments, 2019–2025

Across 39 payments — averaging $123.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson Vision Care, Inc.$4K
  • Coopervision Inc.$402
  • Abbott$194
  • Shire North American Group Inc$121
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$114
  • AbbVie$92
  • plus $47 from 2 others
$330,770in research payments, 2019–2025

Across 27 payments — averaging $12,251 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Johnson & Johnson Vision Care, Inc.$331K

What the payments were for

  • Consulting fees$1,50031%
  • Travel & lodging$1,61934%
  • Food & beverage$1,69235%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,811 in reported general payments places this provider in the 95th percentile of 228 optometrist providers in New Mexico.

See all optometrist providers in New Mexico

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketorolac Tromethamine12$280
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha14$198

Paid to pharmacies, not to this prescriber.

Other optometrist in Albuquerque

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →